Home1VT • FRA
add
Viking Therapeutics Inc
Previous close
€30.21
Day range
€29.62 - €34.55
Year range
€27.35 - €91.50
Market cap
3.80B USD
Avg Volume
418.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 46.24M | 57.89% |
Net income | -35.42M | -43.94% |
Net profit margin | — | — |
Earnings per share | -0.32 | -28.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 902.61M | 149.29% |
Total assets | 908.32M | 146.50% |
Total liabilities | 28.04M | 39.72% |
Total equity | 880.28M | — |
Shares outstanding | 111.57M | — |
Price to book | 3.83 | — |
Return on assets | -12.52% | — |
Return on capital | -12.89% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -35.42M | -43.94% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2012
Website
Employees
31
